Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Beijing Pearl Biotechnology Limited Liability Company

Clinical trials sponsored by Beijing Pearl Biotechnology Limited Liability Company, explained in plain language.

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1

New drug combo shows promise for MET-Positive lung cancer in phase 3 trial

Disease control Recruiting now

This study tests whether adding the targeted drug vebreltinib to standard chemotherapy helps people with a specific type of advanced lung cancer (MET-positive non-squamous NSCLC) live longer without their cancer growing. About 300 adults who have not had prior treatment for their…

Phase: PHASE3 • Sponsor: Beijing Pearl Biotechnology Limited Liability Company • Aim: Disease control

Last updated May 14, 2026 12:02 UTC